Kalia Kumud sold $157K of GH
Kalia Kumud (Chief Information Officer) sold 1,200 shares of Guardant Health, Inc. (GH) at an average of $130.97 ($130.86–$131.08, $0.16M total) across 2 trades over 2026-06-10 to 2026-06-15.
How this was made
The 30-second read
Why it matters
The newest information is the specific open-market sale details (shares, price range, total value, and post-transaction holdings) filed on 2026-06-30 for trades executed mid-June.
Market read
This provides a fresh datapoint on insider behavior, but it is not accompanied by guidance, earnings, or operational developments.
What to watch
No 10b5-1 plan is stated; traders may still treat the absence of a plan as marginally more informative, but the disclosed size remains small.
Background
The article is a SEC Form 4 insider transaction disclosure for Guardant Health, Inc. (GH).
Ticker impact
Guardant Health CIO Kalia Kumud filed an open-market sale of 1,200 shares at ~$130.97 (total ~$157k) on June 10–15, 2026.
Low likelihood of a sustained price move; any impact would be short-lived unless accompanied by other company-specific news.
This is a Form 4 insider transaction with modest dollar value and no 10b5-1 plan stated; the filing itself is new, but it does not disclose new operating/financial information.
Market effects
Minimal; insider selling at a single healthcare/diagnostics name typically does not reset sector expectations.
None indicated; US-listed Form 4 filing with small transaction value.
None indicated; no cross-border deal/regulatory action mentioned.
Counterpoint
The sale could be unrelated to company outlook (tax/portfolio rebalancing), especially since the filing does not indicate distress or a planned program.
Key entities
- issuerGuardant Health, Inc.
US-listed company whose insider transaction was disclosed via Form 4.
- insiderKalia Kumud
Chief Information Officer who sold 1,200 shares in two open-market trades.
